Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Peptides / GHRPs and ghrelin agonists

105 In the index

Ulimorelin ULIM

An experimental medication studied in large human trials for helping bowel function return after surgery. Results didn't consistently meet the study goals, and development for that specific use was stopped.

Also known as TZP-101

Effects Build muscle
Routes Injectable
Legal status Unapproved / investigational
WADA Banned at all times

3D Molecular Structure of C30H39FN4O4

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Fluorine
  • Nitrogen
  • Oxygen

Chemistry

Formula
C30H39FN4O4
Molar mass
538.7
CAS
842131-33-3
PubChem CID
11526696

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established (development discontinued for its studied indication)
Reported range Phase III trial doses: 80-600 mcg/kg IV
Route Intravenous injection
Frequency Per trial protocol (post-surgical use)
Duration Short-term (post-operative trial use)

An investigational ghrelin receptor agonist studied for post-surgical bowel-function recovery; results didn't consistently meet study goals, and development for that use was stopped. Not an approved product.

Where this comes from Published Phase III clinical trial data

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.